Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acutus Medical Inc AFIB

Healthcare Medical Devices
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or... see more

Recent & Breaking News (OTCPK:AFIB)

Acutus Medical to Announce Third Quarter 2022 Financial Results

GlobeNewswire October 27, 2022

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System

GlobeNewswire October 18, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 3, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 1, 2022

SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medical, Inc.

Business Wire August 24, 2022

Acutus Medical Reports Second Quarter 2022 Financial Results

GlobeNewswire August 11, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 2, 2022

Acutus Medical to Announce Second Quarter 2022 Financial Results

GlobeNewswire July 28, 2022

Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan

GlobeNewswire July 27, 2022

Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results

GlobeNewswire July 21, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 1, 2022

Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities

GlobeNewswire July 1, 2022

Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross(TM) Line Extension Compatible with Watchman(TM) Delivery System

GlobeNewswire June 27, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire June 1, 2022

Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System

GlobeNewswire May 13, 2022

Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition

GlobeNewswire May 12, 2022

Acutus Medical to Announce First Quarter 2022 Financial Results

GlobeNewswire April 27, 2022

Acutus Medical Announces Agreements to Fund Strategic Growth Priorities

GlobeNewswire April 27, 2022

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

PR Newswire April 18, 2022

AFIB DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB

Newsfile April 18, 2022